Michigan Medicine researchers are leading a clinical trial to address Dravet syndrome, a severe form of epilepsy. The study is testing a therapy that targets the underlying genetic cause of the condition. Rather than only managing symptoms, the treatment aims to alter the disease’s progression and could mark a new chapter in how genetic epilepsies are treated. Discover how this groundbreaking research could change lives in the full article.
